REGULATION OF LIPOLYSIS BY HUMAN ADIPOSE-TISSUE IN HYPER-THYROIDISM

被引:52
作者
ARNER, P
WENNLUND, A
OSTMAN, J
机构
[1] Karolinska Institute, Department of Internal Medicine, Huddinge Hospital, Huddinge
关键词
D O I
10.1210/jcem-48-3-415
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of noradrenaline (NA) and isopropylnoradrenaline (ISNA) on glycerol release and cAMP levels in sc adipose tissue were studied in vitro in 27 patients with hyperthyroidism. In 11 patients, the studies were repeated after 6-12 months of treatment for hyperthyroidism. A third group comprised 21 euthyroid patients otherwise healthy except for morbid obesity. The lipolytic response to ISNA, observed in untreated thyrotoxic patients, was found to be reduced by 30% when the patients were reexamined after treatment for thyrotoxicosis. This reduction was attributable to a decrease in the cAMP level. This was observed whether adipose tissue was incubated in the presence or absence of a phosphodiesterase inhibitor, theophylline. Both NA and ISNA induced 50% more rapid glycerol release and 4 times higher cAMP levels in adipose tissue of the thyrotoxic subjects than in the obese euthyroid patients. A positive correlation between tissue cAMP and glycerol release, on one hand, and mean fat cell size, on the other hand, was observed in treated thyrotoxic patients and obese euthyroid patients but was not recorded in the untreated hyperthyroid patients. The basal rate of lipolysis was not altered in thyrotoxicosis. The results suggest that the enhanced lipolytic response to catecholamines in adipose tissue of hyperthyroid patients is due to increased β-adrenergic responsiveness. In addition, a disruption in subsequent stages of the regulatory pathway at the level of protein kinase or hormone-sensitive lipase also seems possible. © 1979 by The Endocrine Society.
引用
收藏
页码:415 / 419
页数:5
相关论文
共 36 条
  • [1] EFFECT OF LOCAL ANESTHETIC AGENTS ON LIPOLYSIS BY HUMAN ADIPOSE-TISSUE
    ARNER, P
    ARNER, O
    OSTMAN, J
    [J]. LIFE SCIENCES, 1973, 13 (02) : 161 - 169
  • [2] ARNER P, 1975, Scandinavian Journal of Clinical and Laboratory Investigation, V35, P691, DOI 10.3109/00365517509095799
  • [3] ARNER P, 1978, J LIPID RES, V19, P613
  • [4] ABNORMALITIES IN ADRENERGIC CONTROL AND RATE OF LIPOLYSIS IN ISOLATED HUMAN SUBCUTANEOUS ADIPOSE-TISSUE IN DIABETES-MELLITUS
    ARNER, P
    OSTMAN, J
    [J]. DIABETOLOGIA, 1976, 12 (06) : 593 - 599
  • [5] Bjorntorp P, 1971, Adv Metab Disord, V5, P277
  • [6] BRODIE BB, 1966, PHARMACOL REV, V18, P273
  • [7] BURNS TW, 1970, J LAB CLIN MED, V75, P983
  • [8] CALDWELL A, 1976, ENDOCRINOLOGY, V89, P1195
  • [9] Chernick S, 1969, METH ENZYMOLOGY, V14, P627
  • [10] DEBONS AF, 1961, J LIPID RES, V2, P86